P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.

P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.

Bibliographic Details
Main Authors: J. Xavier-Ferrucio, C. Luo, G. Angelini, S. Krishnamurthy, N. Patel, M. Pettiglio, T. Collingsworth, M. Isik, A. Ghodssi, A. Halfond, J. Etchin, Y. Keschner, G. Mundelboim, P. Tavares, C. Cummins, A. Falla, D. Hazelbaker, E. Paik, J. Sanchez, G. Ge, J. Lydeard, M. I. Lin, T. Chakraborty
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000848572.60330.2f

Similar Items

Similar Items